Download
https://www.ndtvprofit.com/quarterly-earnings/glenmark-pharma-q3-results-reports-net-loss-of-rs-331-crore?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The Mumbai-based bulk and generic drugmaker reported a net loss of Rs 331 crore, as compared with a net profit of Rs 291 crore over the same period last year.
Share